The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, hepatic cytochrome P450 reductase null (HRN™) mice and pure enzymes - Stiborová, Marie; Černá, Věra; Moserová, Michaela; Mrízová, Iveta; Arlt, Volker M.; Frei, Eva (International journal of molecular sciences, 2015)
Published: 25 December 2014